BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 15, 2011
 |  BC Week In Review  |  Company News  |  Other News

Merck cancer, infectious news

Merck received a subpoena from the U.S. Department of Justice regarding the marketing of cancer drug Temodar temozolomide, HCV drug PegIntron peginterferon alfa-2b and cancer and viral infection drug...

Read the full 145 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >